直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • 新闻
  • 飞翰事实
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • 慈善性法律援助
  • 管理层
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

In the First Post-Bilski Consideration of Section 101, Federal Circuit Finds the Process Patent is Valid, Undoes Microsoft Win Against RCT (Again)

December 9, 2010

The AmLaw Litigation Daily

This article discusses the first case in which the U.S. Court of Appeals for the Federal Circuit has considered patentability under Section 101 of the Patent Act in the wake of the U.S. Supreme Court's ruling in Bilski v. Kappos. In this decision, a three-judge appellate panel concluded that Arizona federal district court judge Robert Jones erred when he ruled that claims in two patents held by Research Corporation Technologies Inc. (“RCT”), were invalid because they covered non-patentable material. The ruling reverses, for the second time, a district court win for Microsoft. J. Michael Jakes, a partner at Finnegan, made the winning appellate argument for RCT as well as represented Bilski.  "It's the first post-Bilski decision on Section 101, so people are interested to read it," said Jakes about the RCT case. "We think Judge Rader's opinion takes a correct and very broad view of Section 101." RCT is represented by Finnegan.

Related Professionals

J. Michael Jakes
合伙人
Washington, DC
+1 202 408 4045
Email

Related News

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Commentary

ITC Bars Import of Innoscience Chips Made Before Redesign

May 8, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Award/Ranking

Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey

May 7, 2026

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP